๐Ÿ‡ฎ๐Ÿ‡ชIreland
16ยฐC Partly Cloudy ยท Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› Suzhou
Clinical trial register · China

Clinical Trials in Suzhou, 2026

Every study on the ClinicalTrials.gov registry that lists a site in China and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage โ€” all 19052 matching records held by the registry are in this view. Synced 22 Sep 2026, 11:10 UTC
19052
Studies in scope
all four open statuses
11786
Recruiting now
open to new participants
2009
Lead sponsors
across recruiting studies
Top sites
Beijing 5484 Shanghai 3827 Guangzhou 3318 Hangzhou 1812 Wuhan 1343
Narrow the registerReset
Recruitment status
Phase
Lead sponsor
The First Affiliated Hospital of Soochow University115 Second Affiliated Hospital of Soochow University16 Capital Medical University9 Novartis Pharmaceuticals8 Takeda8
Site location
Beijing5484 Shanghai3827 Guangzhou3318 Hangzhou1812 Wuhan1343
All 613 locations
Target enrolment
to

Trials with a site in Suzhou

421 of 19052 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Chinese sites
Start
Recruiting
Combination Regimen of Teniposide, PD-1 Monoclonal Antibody and Selinixor for Patients With Relapsed or Refractory PCNSL
NCT07074470Primary Central Nervous System Lymphoma (PCNSL)
The First Affiliated Hospital of Soochow University
Not applicable
40
Suzhou
2025-01-02
Recruiting
A Technique Improves Urinary Continence in Patients Undergoing Laparoscopic Radical Prostatectomy
NCT06754488Posterior Bladder Wall Reconstruction, Anterior Bladder Wall Reconstruction, Anterior Bladder Wall Suspension
Suzhou Municipal Hospital
Not applicable
120
Suzhou
2025-01-01
By invitation
Clinical Efficacy of Intermittent Theta Burst Transcranial Magnetic Stimulation With Different Modes on Parkinson's Disease
NCT07176091Parkinsonism, Transcranial Magnetic Stimilation, Intermittent Theta Burst Stimulation, Primary Motor Cortex
Second Affiliated Hospital of Soochow University
Not applicable
90
Suzhou
2025-01-01
Recruiting
BN104 in Combination With Chemotherapy or Targeted Agents for Acute Myeloid Leukemia
NCT06746519Acute Myeloid Leukemia
Chen Suning
Phase 1/2
135
Suzhou
2024-12-25
Recruiting
ICP-248 in Combination With Azacitidine for the Treatment in Patients With Myeloid Malignancies
NCT06656494Acute Myelogenous Leukemia, Myelodysplastic Syndromes (MDS)
Beijing InnoCare Pharma Tech Co., Ltd.
Phase 1
266
Hefei, Beijing, Chongqing, Guangzhou, Zhengzhou, Wuhan, Suzhou, Nanchang
2024-12-18
Recruiting
A Study of Maribavir in Chinese Adults With Cytomegalovirus (CMV) Infections
NCT06439342Cytomegalovirus (CMV)
Takeda
Phase 3
20
Hefei, Chongqing, Guangzhou, Zhengzhou, Wuhan, Suzhou, Beijing, Tianjin
2024-12-16
Recruiting
Efficacy of Extended Letermovir Prophylaxis to Prevent CMV Reactivation in High-Risk Chinese Adults Undergoing Allogeneic HSCT
NCT06812598Cytomegalovirus Infections, CMV
The First Affiliated Hospital of Soochow University
Not applicable
330
Suzhou
2024-12-16
Recruiting
Integrated Radiotherapy-optimized ASCT Sequential CAR-T Therapy for Patients With Relapsed and Refractory B-NHL
NCT07059741Aggressive B-Cell Non-Hodgkin's Lymphoma (NHL)
The First Affiliated Hospital of Soochow University
Not applicable
20
Suzhou
2024-12-10
Recruiting
A Single-arm, Prospective Study of TBI + BUMEL As a Conditioning Regimen for Salvage HSCT in Patients with R/R AML
NCT06879847Relapsed or Refractory Acute Myeloid Leukemia
The First Affiliated Hospital of Soochow University
Not applicable
40
Suzhou
2024-12-01
Recruiting
Repeated Transcranial Magnetic Stimulation for the Treatment of Diarrhea-Predominant Irritable Bowel Syndrome: A Randomized Clinical Trial
NCT07581756Irritable Bowel Syndrome, Irritable Bowel Syndrome With Diarrhea (IBS-D), Repetitive Transcranial Magnetic Stimulation (rTMS), Chronic Diarrhea
The First Affiliated Hospital of Soochow University
Not applicable
46
Suzhou
2024-12-01
Recruiting
Efficacy of Repeated Transcranial Magnetic Stimulation Combined With a Live Probiotic Tablet (Combined Bifidobacterium, Lactobacillus, Enterococcus and Bacillus Cereus Tablets, Live) in Diarrhea-Predominant Irritable Bowel Syndrome (IBS-D)
NCT06960369Irritable Bowel Syndrome, Irritable Bowel Syndrome With Diarrhea (IBS-D), Repetitive Transcranial Magnetic Stimulation (rTMS), Probiotic
The First Affiliated Hospital of Soochow University
Phase 1
400
Suzhou
2024-12-01
Recruiting
Allogeneic CD19-targeted CAR-ฮณฮดT Cell Infusion Therapy in Relapsed/Refractory B Cell Acute Lymphoblastic Leukemia
NCT06696833B-Cell Acute Lymphoblastic Leukemia, Adult
The First Affiliated Hospital of Soochow University
Phase EARLY_PHASE1
18
Suzhou
2024-12-01
Not yet open
BuCy Vs. TBICy for Allo-HSCT in T-ALL Patients
NCT06673459T-Cell Lymphocytic Leukemia, ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION, Total Body Irradiation, Chemotherapy
The First Affiliated Hospital of Soochow University
Phase 3
430
Suzhou
2024-12-01
Not yet open
The Exploration of Personalized ctDNA Based MRD in the Clinical Significance of Cervical Cancer
NCT06283875Ovarian Cancer
Geneplus-Beijing Co. Ltd.
Observational
80
Suzhou
2024-12-01
Not yet open
Study of Transcatheter Aortic Valve Replacement With Aยฒ Flex and Commissural Alignment Technology in Severe Aortic Stenosis
NCT06721676Aortic Stenosis Symptomatic
Peijia Medical Technology (Suzhou) Co., Ltd.
Not applicable
10
Suzhou
2024-12
Recruiting
The Impact of Local Anesthetic Solution Temperature on Epidural-related Maternal Fever
NCT06682416Epidural Related Maternal Fever, Analgesia, Epidural, Fever, Intrapartum Fever
The First Affiliated Hospital of Soochow University
Not applicable
424
Suzhou
2024-11-30
Recruiting
A Study to Investigate Safety and Effectiveness of Tacabrutideg (BGB-16673) in Combination With Other Agents in Participants With Relapsed or Refractory B-Cell Malignancies
NCT06634589B-cell Malignancy, Relapsed Cancer, Refractory Cancer, B-cell Lymphoma
BeOne Medicines
Phase 1/2
80
Fuzhou, Guangzhou, Suzhou, Hangzhou, Wenzhou
2024-11-27
Active, closed
A Study to Learn About the Study Medicine Called Rimegepant in Adolescents With Frequent Migraine
NCT06616194Migraine
Pfizer
Phase 3
200
Beijing, Chongqing, Guangzhou, Jingzhou, Wuhan, Changsha, Suzhou, Wuxi
2024-11-15
Recruiting
Glofitamab Bridging ASCT for Patients With Relapsed or Refractory DLBCL
NCT06682130Diffuse Large B-cell Lymphoma(DLBCL)
The First Affiliated Hospital of Soochow University
Phase 2
40
Suzhou
2024-11-10
Recruiting
Early Antiplatelet Administration After Intravenous Thrombolysis for Acute Ischemic Stroke (TREND-IVT)
NCT06548971Acute Ischemic Stroke, Cerebral Infarction
Capital Medical University
Phase 3
1,184
Bengbu, Suzhou, Beijing, Haidian, Pinggu, Tongzhou, Fuzhou, Xiamen
2024-11-07
Recruiting
89Zr-TLX250 for PET/CT Imaging of ccRCC - ZIRCON-CP Study
NCT06750419Clear Cell Renal Cell Carcinoma
Telix Pharmaceuticals (Innovations) Pty Limited
Phase 3
82
Beijing, Hangzhou, Hubei, Shanghai, Suzhou, Tianjin, Wuxi, Zhejiang
2024-11-06
Recruiting
Chidamide Combined With Brentuximab Vedotin Regimen for CD30+ PTCL Patients
NCT07074457CD30+ Peripheral T-cell Lymphoma
The First Affiliated Hospital of Soochow University
Not applicable
47
Suzhou
2024-11-01
Recruiting
Pomalidomide, Rituximab and Orelabrutinib Combined With Polatuzumab Vedotin in the Treatment of Newly Diagnosed Elderly Patients With DLBCL
NCT07072208Diffuse Large B-Cell Lymphoma
The First Affiliated Hospital of Soochow University
Not applicable
43
Suzhou
2024-11-01
Recruiting
Bendamustine Combined With Chidamide and Lenalidomide for Relapsed and Refractory PTCL Patients
NCT07072221Peripheral T-cell Lymphoma
The First Affiliated Hospital of Soochow University
Not applicable
40
Suzhou
2024-11-01
Active, closed
Regular Physical Exercise in Patients With Symptomatic Intracranial Arterial Stenosis
NCT06615726Ischemic Stroke, Transient Ischemic Attack
Capital Medical University
Phase 3
1,300
Fuyang, Huainan, Suzhou, Wuhu, Beijing, Chongqing, Zhangzhou, Foshan
2024-10-10
Recruiting
Time Restricted Eating in Childhood Obesity (TRECO)
NCT06583447Childhood Obesity
Xiaoyan Shi
Not applicable
128
Suzhou
2024-09-28
Recruiting
Remote Ischemic Conditioning for Acute Ischemic Stroke Treated With Mechanical Thrombectomy๏ผˆRECAST-MT๏ผ‰
NCT06559241Acute Ischemic Stroke, Anterior Circulation Brain Infarction
Capital Medical University
Phase 3
2,105
Suzhou, Taihe Chengguanzhen, Tongling, Beijing, Fuzhou, Zhangzhou, Shenzhen, Nanning
2024-09-23
Recruiting
A Clinical Study to Evaluate the Safety, Tolerability, and Preliminary Efficacy of B019 Injection in Subjects With Relapsed or Refractory B-cell Acute Lymphoblastic Leukemia.
NCT06927466Relapsed or Refractory B-cell Acute Lymphoblastic Leukemia
Shanghai Pharmaceutical Group Biological Therapy Technology Co., Ltd.
Phase 1
33
Beijing, Nanchang, Shanghai, Suzhou, Wuhan, Xuzhou
2024-09-19
Recruiting
Conversion to Carfilzomib Therapy in Bortezomib Intolerant Newly Diagnosed Multiple Myeloma(NDMM) Patients
NCT06682156Newly Diagnosed Multiple Myeloma
The First Affiliated Hospital of Soochow University
Observational
50
Suzhou
2024-09-10
Recruiting
Pharmacokinetic Study of Sudapyridine๏ผˆWX-081๏ผ‰in Healthy Chinese Subjects
NCT06701110TB
Shanghai Jiatan Pharmatech Co., Ltd
Phase 1
10
Suzhou
2024-09-04
Not yet open
Hema-NeoTIL01 Cell Infusion Therapy in Relapsed/Refractory Acute Leukemia
NCT06559644Leukemia, Myeloid, Acute, B-cell Acute Lymphoblastic Leukemia
The First Affiliated Hospital of Soochow University
Phase EARLY_PHASE1
20
Suzhou
2024-09-01
Not yet open
HPP737 Substance Balance Study in Human
NCT06584058Psoriasis
Newsoara Biopharma Co., Ltd.
Not applicable
8
Suzhou
2024-08-30
Recruiting
A Study To Characterize Mass Balance Of [14C] HDM1002 in Chinese Healthy Subjects
NCT06576401Healthy Adult Subject
Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd.
Phase 1
10
Suzhou
2024-08-27
Active, closed
A Study of Obexelimab in Patients With Relapsing Multiple Sclerosis (MoonStone)
NCT06564311Relapsing Multiple Sclerosis
Zenas BioPharma (USA), LLC
Phase 2
93
Beijing, Suzhou, Tianjin, รœrรผmqi, Wuhan
2024-08-26
Recruiting
A Study of Intravesical FL115 Alone or in Combination With BCG in Non-Muscle Invasive Bladder Cancer
NCT07122414Non-muscle Invasive Bladder Cancer (NMIBC)
Suzhou Forlong Biotechnology Co., Ltd
Phase 1/2
80
Beijing, Fuzhou, Wenzhou, Changsha, Nanjing, Suzhou, Qingdao, Chengdu
2024-08-16
Active, closed
Evaluate the Efficacy and Safety of Xianglei Tangzu Gao for the Treatment of Wagner Grade II Diabetic Foot Ulcers
NCT06531512Diabetic Foot Ulcer
Oneness Biotech Co., Ltd.
Phase 2/3
120
Jiangmen, Luoyang, Suzhou, Zhenjiang, Shenyang, Xi'an, Hangzhou, Guangzhou
2024-08-16
Recruiting
A Study of HDM2005 in Patients With Relapsed/Refractory B-cell Lymphoma and Advanced Solid Tumor
NCT06615193Advanced Solid Tumors, Refractory Lymphoma, Relapsed Hematologic Malignancy
Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd.
Phase 1
111
Zhengzhou, Suzhou, Xuzhou, Nanchang, Jinan, Hangzhou, Tianjing
2024-08-12
Recruiting
A Comparing Study Between SJ04 and Ovidrelยฎ in Healthy Subjects
NCT06599528Assisted Reproductive Technology, Female Infertility
Suzhou Centergene Pharmaceuticals Co.,Ltd.
Phase 1
48
Suzhou
2024-08-12
Recruiting
Current Status of Treatment for Chinese Patients With ESR1-mutated HR+/HER2-advanced Breast Cancer
NCT06548919ESR1 Gene Mutation, Advanced Breast Cancer
SciClone Pharmaceuticals
Observational
450
Suzhou
2024-08-08
Active, closed
Evaluation of Efficacy and Safety of Prolia in Subjects of Male Osteoporosis in Mainland China
NCT06332014Osteoporosis
Amgen
Phase 4
102
Beijing, Chongqing, Guangzhou, Harbin, Huaian, Nanjing, Suzhou, Xuzhou
2024-08-06
Recruiting
Lf-rTMS Attenuates Visceral Pain in Irritable Bowel Syndrome With Diarrhea
NCT06757491Repetitive Transcranial Magnetic Stimulation, Chronic Visceral Pain, Functional Magnetic Resonance Imaging, IBS (Irritable Bowel Syndrome)
The First Affiliated Hospital of Soochow University
Not applicable
42
Suzhou
2024-08-01
Recruiting
Efficacy of Ustekinumab Therapy in Patients With Symptomatic Stricturing Crohn's Disease
NCT05387031Crohn Disease, Stricture; Bowel, Intestinal Stricture
Second Affiliated Hospital, Zhejiang University, School of Medicine
Observational
239
Beijing, Chongqing, Guangzhou, Huai'an, Suzhou, Yangzhou, Hangzhou
2024-08-01
Active, closed
A Phase III Study to Investigate Efficacy, Safety and Tolerability of Iptacopan Compared With Placebo in Participants Aged 18 to 85 Years With gMG.
NCT06517758Generalized Myasthenia Gravis
Novartis Pharmaceuticals
Phase 3
146
Hefei, Guangzhou, Shenzhen, Shijiazhuang, Changsha, Suzhou, Xi'an, Xianyang
2024-07-31
Recruiting
Comparison of VA (Venetoclax, Azacitidine), VACl (VA, Cladribine), VACh (VA, Chidamide), and Alternating VACl/VACh in Newly Diagnosed Acute Myeloid Leukemia
NCT06532552Acute Myeloid Leukemia, Adult, Newly Diagnosed
The First Affiliated Hospital of Soochow University
Phase 2
172
Suzhou
2024-07-29
Recruiting
A Study of IBI3003 in Subjects With Relapsed or Refractory Multiple Myeloma
NCT06083207Multiple Myeloma
Innovent Biologics (Suzhou) Co. Ltd.
Phase 1/2
116
Beijing, Nanning, Wuhan, Nanjing, Suzhou, Xuzhou, Nanchang, Shanghai
2024-07-29
Active, closed
Study of Blinatumomab Administration in Chinese Pediatric Participants With Relapsed/Refractory B Precursor Acute Lymphoblastic Leukemia (R/R B-ALL)
NCT06054113B Precursor Acute Lymphoblastic Leukemia, Relapsed/Refractory B Precursor Acute Lymphoblastic Leukemia
Amgen
Phase 2
18
Hefei, Chongqing, Guangzhou, Wuhan, Suzhou, Shanghai, Tianjin
2024-07-23
Recruiting
TP03HN106 in Patients With Critical Limb Ischemia
NCT06482892Critical Limb Ischemia
Talengen Institute of Life Sciences, Shenzhen, P.R. China.
Phase 2
15
Suzhou
2024-07-18
Recruiting
A Single-Arm, Prospective Study of TBI+BUMEL as Conditioning for SCT2 in Patients With Malignant Hematologic Diseases
NCT06548958Malignant Hematological Diseases
The First Affiliated Hospital of Soochow University
Not applicable
40
Suzhou
2024-07-10
Active, closed
Safety and Efficacy of Tocilizumab in Patients With Myelin Oligodendrocyte Glycoprotein Antibody-associated Disease
NCT06452537Myelin Oligodendrocyte Glycoprotein Antibody-associated Disease
Tianjin Medical University General Hospital
Phase 2/3
102
Hefei, Lanzhou, Shijiazhuang, Harbin, Zhenzhou, Ordos, Changzhou, Suzhou
2024-07-09
Recruiting
CMOPยฑR in the Treatment of Untreated Non-Hodgkin's Lymphoma
NCT06486337NHL
The First Affiliated Hospital of Soochow University
Phase 2
197
Suzhou
2024-07-08
Recruiting
A Clinical Study Comparing SG301 Plus Pomalidomide and Dexamethasone to Placebo Plus Pomalidomide and Dexamethasone in Relapsed or Refractory Multiple Myeloma Patients
NCT06508983Relapsed/Refractory Multiple Myeloma
Hangzhou Sumgen Biotech Co., Ltd.
Phase 3
360
Beijing, Guangzhou, Luoyang, Zhengzhou, Wuhan, Suzhou, Taiyuan, Xiโ€™an
2024-06-14
Recruiting
Treatment of High-risk Newly Diagnosed Multiple Myeloma With Minimal Residual Disease Detection
NCT06409702Newly Diagnosed, High Risk, MRD, Multiple Myeloma
The First Affiliated Hospital of Soochow University
Phase 4
59
Suzhou
2024-06-12
Recruiting
A Study of GLB-001 in Patients With Myeloid Malignancies
NCT06378437Polycythemia Vera, Essential Thrombocythemia, Myelofibrosis, Myelodysplastic Syndromes
Hangzhou GluBio Pharmaceutical Co., Ltd.
Phase 1
108
Hefei, Beijing, Chongqing, Shijiazhuang, Zhengzhou, Wuhan, Suzhou, Nanchang
2024-05-24
Recruiting
Phase 3 Extension Study to Evaluate Long-term Safety of Ianalumab in Participants With Systemic Lupus Erythematosus (SIRIUS-SLE Extension).
NCT06133972Systemic Lupus Erythematosus
Novartis Pharmaceuticals
Phase 3
550
Guangzhou, Shantou, Nanjing, Suzhou, Nanchang, Pingxiang, Changchun, Linyi
2024-05-21
Active, closed
Study Assessing Activity of Intravenous (IV) Etentamig Monotherapy Versus Standard Available Therapies in Adult Participants With Relapsed or Refractory Multiple Myeloma
NCT06158841Multiple Myeloma
AbbVie
Phase 3
421
Beijing, Fuzhou, Guangzhou, Zhengzhou, Wuhan, Nanjing, Suzhou, Nanchang
2024-05-19
Active, closed
N-Acetylcysteine as Therapy for Transplantation- Associated Thrombotic Microangiopathy
NCT07279610Thrombotic Microangiopathy
The First Affiliated Hospital of Soochow University
Phase 2/3
44
Suzhou
2024-05-01
Not yet open
Neoadjuvant Radiohormonal Therapy for Oligometastatic Prostate Cancer
NCT05707468Oligometastatic Prostate Carcinoma
Changhai Hospital
Not applicable
200
Guangzhou, Suzhou, Wuxi, Ningbo, Shanghai
2024-05-01
Recruiting
Decitabine, Venetoclax and Blinatumomab for Maintenance Following HSCT in Patients With Ph-Negative B-ALL
NCT06393985B-cell Acute Lymphoblastic Leukemia
The First Affiliated Hospital of Soochow University
Phase 2
30
Suzhou
2024-04-25
Active, closed
Study to Evaluate Efficacy and Safety of Romosozumab Compared With Bisphosphonates in Children and Adolescents With Osteogenesis Imperfecta
NCT05972551Osteogenesis Imperfecta
Amgen
Phase 3
111
Beijing, Shenzhen, Wuhan, Suzhou, Changchun, Jinan, Chengdu, Shanghai
2024-04-22
Recruiting
Efficacy of Songling Xuemaikang Capsules on Grade 1 Hypertension: a Randomized Controlled Trial
NCT06093932Hypertension,Essential
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Phase 4
100
Beijing, Suzhou, Jinan, Jining, Taiyuan
2024-04-07
Recruiting
A Study to Assess Efficacy and Safety of Pembrolizumab With or Without Sacituzumab Tirumotecan (MK- 2870) in Adult Participants With Resectable Non Small Cell Lung Cancer (NSCLC) Not Achieving Pathological Complete Response (pCR) (MK-2870-019)
NCT06312137Non Small Cell Lung Cancer
Merck Sharp & Dohme LLC
Phase 3
780
Beijing, Fuzhou, Guangzhou, Zhengzhou, Wuhan, Changsha, Nanjing, Suzhou
2024-04-03
Recruiting
VA vs DA for Newly Diagnosed Hig-risk AML
NCT05939180Acute Myeloid Leukemia
The First Affiliated Hospital of Soochow University
Phase 2/3
116
Suzhou
2024-04-01
Recruiting
UTAA17 Injection in the Treatment of Relapsed/Refractory Multiple Myeloma
NCT06279026Relapsed/Refractory Multiple Myeloma
PersonGen BioTherapeutics (Suzhou) Co., Ltd.
Not applicable
15
Suzhou
2024-04-01
Recruiting
Haplo-cord HCT vs. Haplo-HCT for T-ALL Patients
NCT06381817Acute T Cell Lymphoblastic Leukemia, Haploidentical Hematopoietic Stem Cell Transplantation, Cord Blood
The First Affiliated Hospital of Soochow University
Phase 3
146
Suzhou
2024-04-01
Recruiting
Blinatumomab and Auto-HSCT Sandwich Strategy as Consolidation Therapy for B-ALL
NCT06507514B-cell Acute Lymphoblastic Leukemia
The First Affiliated Hospital of Soochow University
Phase 1
4
Suzhou
2024-04-01
Recruiting
Study of IBR733 Cell Injection in Acute Myeloid Leukemia
NCT06234904Acute Myeloid Leukemia
Imbioray (Hangzhou) Biomedicine Co., Ltd.
Phase 1
18
Suzhou
2024-03-26
Recruiting
Clinical Study of TQB2868 Injection Combined With Anlotinib Capsule and Chemotherapy in the First-line Treatment of Metastatic Pancreatic Neoplasms
NCT06767813Pancreatic Neoplasms
Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd.
Phase 2
80
Zhengzhou, Nanjing, Suzhou, Shanghai, Wenzhou
2024-03-19
Recruiting
An Efficacy and Safety Study of Intravenous Anifrolumab to Treat Systemic Lupus Erythematosus in Pediatric Participants
NCT05835310Systemic Lupus Erythematosus
AstraZeneca
Phase 3
100
Beijing, Changchun, Changsha, Dongguan, Nanjing, Shanghai, Suzhou, Wenzhou
2024-03-14
Active, closed
Effects of the Combined Intervention of Exercise, Fruit, and Vitamin Supplementation on Frailty in Older Adults
NCT06225271Frailty
Nanjing Medical University
Not applicable
934
Suzhou
2024-03-08
Recruiting
A Study on the Safety of TAK-279 and Whether it Can Reduce Inflammation in the Bowel of Participants With Moderately to Severely Active Crohn's Disease
NCT06233461Crohn's Disease
Takeda
Phase 2
268
Chongqing, Xiamen, Guangzhou, Huizhou, Wuhan, Changsha, Changzhou, Suzhou
2024-03-05
Recruiting
Focused Power Ultrasound Mediated Inferior Perirenal Adipose Tissue Modification Therapy for Essential Hypertension (PARADISE HTN-III)
NCT06283758Hypertension, Blood Pressure, Cardiovascular Diseases
Suzhou Municipal Hospital
Not applicable
30
Nanjing, Nantong, Suzhou
2024-03-01
Recruiting
Safety and Efficacy of Avapritinib in Relapsed or Refractory Pediatric CBF-AML With KIT Mutation
NCT06316960AML, Childhood, Relapse/Recurrence, Refractory AML, Core Binding Factor Acute Myeloid Leukemia
Children's Hospital of Soochow University
Phase 2
50
Hefei, Guangzhou, Nanning, Kaifeng, Zhengzhou, Changsha, Suzhou, Xuzhou
2024-03-01
Recruiting
The Effect of LIPUS on the Maturation of Newly Constructed Autogenous AVF
NCT06249373Uremia; Chronic
Suzhou Municipal Hospital
Not applicable
300
Suzhou
2024-02-26
Not yet open
Plasma cfDNA Testing Guiding the Treatment Decisions of DLBCL
NCT06289959Lymphoma, Large B-Cell, Diffuse
Second Affiliated Hospital of Soochow University
Not applicable
30
Suzhou
2024-02-25
Recruiting
Study of VA Combined With HAAG Regimen in Newly Diagnosed Intermediate and High-risk AML Patients
NCT06394011Intermediate Risk Acute Myeloid Leukemia, High Risk Acute Myeloid Leukemia
The First Affiliated Hospital of Soochow University
Phase 2
60
Suzhou
2024-02-15
Recruiting
RDC-Blinatumomab Versus hyperCVAD for Ph-negative B-ALL.
NCT06250959ALL, Adult, Philadelphia-Negative ALL
Chen Suning
Phase 2
124
Suzhou
2024-02-05
Recruiting
VAC Regimen for AML Patients Who Failed to Response to VA Regimen
NCT06220162Acute Myeloid Leukemia
The First Affiliated Hospital of Soochow University
Phase 2
32
Suzhou
2024-02-01
Recruiting
Myasthenia Gravis Registry in China
NCT06241521Myasthenia Gravis
Huashan Hospital
Observational
1,500
Beijing, Chongqing, Guangzhou, Zhengzhou, Changsha, Suzhou, Xuzhou, Nanchang
2024-02-01
Recruiting
A Clinical Study of Darcilil Combined With AI Combined With Pyrrotinib in the Treatment of TPBC
NCT06235931Breast Neoplasms
Second Affiliated Hospital of Soochow University
Not applicable
34
Suzhou
2024-02-01
Recruiting
Safety and Efficacy of NRT6008 in Patients With Unresectable Locally Advanced Pancreatic Cancer (LAPC) and Advanced Pancreatic Cancer With Lymph Node Metastases
NCT06278454Unresectable Pancreatic Cancer, Advanced Pancreatic Cancer, Lymph Node Metastases
Chengdu New Radiomedicine Technology Co. LTD.
Phase 1
58
Zhengzhou, Suzhou, Shanghai, Chongqing, Tianjin
2024-01-09
Recruiting
Rescue Endovascular Therapy for Progressive Acute Mild Ischemic Stroke With Large Vascular Occlusion
NCT06155032Stroke, Ischemic, Cerebrovascular; Disorder, Occlusive
First Affiliated Hospital of Wannan Medical College
Not applicable
272
Fuyang, Hefei, Huainan, Huangshan City, Suzhou, Wuhu, Xiangyang
2024-01-04
Recruiting
Evaluation of the Safety and Efficacy of Hemophilia A Gene Therapy Drugs
NCT06111638Hemophilia A
Shanghai Xinzhi BioMed Co., Ltd.
Phase 2/3
55
Beijing, Guangzhou, Guiyang, Wuhan, Changsha, Suzhou, Xiโ€™an, Chengde
2024-01-03
Active, closed
Study of A Venetoclax-based, Anthracycline-free Regimen in Newly Diagnosed CBFฮฒ::MYH11(+) AML
NCT06429098Acute Myeloid Leukemia
The First Affiliated Hospital of Soochow University
Phase 2
40
Suzhou
2024-01-01
Recruiting
Efficacy, Safety, and Pharmacokinetics of ThisCART19A Combined With Olverembatinib in Patients With Newly Diagnosed Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia.
NCT07074496Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia
The First Affiliated Hospital of Soochow University
Phase EARLY_PHASE1
20
Suzhou
2024-01-01
Recruiting
Clinical Study of Induction Therapy Options Based on Molecular Subtyping and MRD in Children and Adolescents With AML
NCT06221683AML, Childhood, Acute Myeloid Leukemia
Children's Hospital of Soochow University
Phase 2
500
Hefei, Guangzhou, Nanning, Kaifeng, Zhengzhou, Changsha, Suzhou, Xuzhou
2024-01-01
Recruiting
A Study to Assess BMS-986458 Alone and in Combination With Anti-lymphoma Agents in Relapsed/Refractory Non-Hodgkin Lymphomas
NCT06090539Relapsed/Refractory Non-Hodgkin Lymphoma
Bristol-Myers Squibb
Phase 1/2
460
Beijing, Guangzhou, Zhengzhou, Suzhou, Nanchang, Shenyang, Shanghai, Hangzhou
2023-12-29
Recruiting
AZD0486 as Monotherapy in B-cell Acute Lymphoblastic Leukaemia
NCT06137118B-cell Acute Lymphoblastic Leukemia (B-ALL)
AstraZeneca
Phase 1/2
255
Changsha, Chengdu, Guangzhou, Hangzhou, Nanjing, Suzhou, Tianjin, Zhengzhou
2023-12-29
Recruiting
Phase 1/2 Clinical Study of Lutetium Lu 177 JH020002 Injection in Patients With Advanced Prostate Cancer
NCT06139575Prostate Cancer
Bivision Pharmaceuticals, Inc.
Phase 1/2
90
Hefei, Beijing, Fuzhou, Guangzhou, Zhengzhou, Wuhan, Suzhou, Wuxi
2023-12-22
Recruiting
To Evaluate the Efficacy and Safety of Genalumab for Injection in the Treatment of Active Systemic Juvenile Idiopathic Arthritis.
NCT05925452Active Systemic Juvenile Idiopathic Arthritis
Changchun GeneScience Pharmaceutical Co., Ltd.
Not applicable
290
Beijing, Chongqing, Changsha, Nanjing, Suzhou, Shanghai, Xiโ€™an, Chengdu
2023-12-01
Recruiting
Efficacy and Safety of Colistimethate Sodium for Injection in The Treatment of Carbapenem-Resistant Enterobacteriaceae Infection
NCT06051513Carbapenem-Resistant Enterobacteriaceae Infection
Southeast University, China
Not applicable
404
Hefei, Jinjiang, Huai'an, Lianyungang, Nanjing, Nantong, Suzhou, Taizhou
2023-11-27
Recruiting
Evaluation of the Effect of Finerenone on Renal Function in Patients With Type 2 Diabetes and Chronic Kidney Disease
NCT06838416Type 2 Diabetes Mellitus, Chronic Kidney Disease, Renal Function
Second Affiliated Hospital of Soochow University
Observational
300
Suzhou
2023-11-17
Recruiting
Repetitive Transcranial Magnetic Stimulation Therapy in Essential Tremor
NCT06145932Essential Tremor
Second Affiliated Hospital of Soochow University
Not applicable
40
Suzhou
2023-11-07
Active, closed
Relmacabtagene Autoleucel As Second-Line Therapy in Adult Patients with Aggressive B-cell NHL
NCT06093841Lymphoma, Large B-Cell, Diffuse, Follicular Lymphoma Grade 3B, High-grade B-cell Lymphoma, Mediastinal B-Cell Diffuse Large Cell Lymphoma
Shanghai Ming Ju Biotechnology Co., Ltd.
Phase 2
46
Guangzhou, Zhengzhou, Changsha, Suzhou, Jinan, Shanghai, Tianjin, Hangzhou
2023-11-03
Recruiting
TBI/Flu/Bu/Mel Combined With Secondary UCBT in Patients With Hematological Malignancies Who Relapsed After Allo-HSCT
NCT06125483Hematopoietic Malignancy, Relapse/Recurrence, Hematopoietic Stem Cell Transplantation
The First Affiliated Hospital of Soochow University
Not applicable
38
Suzhou
2023-11-01
Active, closed
XS005 Injection Combined With Stupp Regimen for Adjuvant Chemotherapy in Subjects With Primary Glioblastoma(GBM)
NCT06147505Tumor
Dushu Lake Hospital Affiliated to Soochow University
Phase 1/2
13
Suzhou
2023-10-29
Not yet open
The Prospective Clinical Study of Precision PRaG Therapy in Elderly Patients With Advanced Solid Malignant Tumors (PRaG9.0)
NCT06112041Carcinoma, Solid Tumor
Second Affiliated Hospital of Soochow University
Phase 2
29
Suzhou
2023-10-25
Active, closed
A Study of BN104 in the Treatment of Acute Leukemia
NCT06052813ALL, Adult, AML, Adult, Acute Leukaemia, KMT2A Rearrangement
Institut de Recherches Internationales Servier (I.R.I.S.)
Phase 1/2
66
Suzhou
2023-10-19
Recruiting
Randomized Study of Conditioning of Fludarabine Combined With Single or Dual Alkylating Agents in Myeloid Malignancies
NCT05991908Acute Myeloid Leukemia, Myelodysplastic Syndromes
Shanghai Jiao Tong University School of Medicine
Phase 3
222
Fuzhou, Xiamen, Nanning, Nanjin, Suzhou, Shanghai, Kunming
2023-10-19
Recruiting
Study of Oral Upadacitinib and Subcutaneous/Intravenous Tocilizumab to Evaluate Change in Disease Activity, Adverse Events and How Drug Moves Through the Body of Pediatric and Adolescent Participants With Active Systemic Juvenile Idiopathic Arthritis.
NCT05609630Juvenile Idiopathic Arthritis
AbbVie
Phase 3
90
Chongqing, Suzhou, Xi'an, Shanghai, Hangzhou
2023-10-02
Recruiting
A Study of Comparing Overall Improvement of Patients With Spondyloarthritis Treated With Jitongning Tablets and Placebo
NCT06000956Ankylosing Spondylitis
Tasly Pharmaceutical Group Co., Ltd
Phase 3
408
Beijing, Lanzhou, Shijiazhuang, Luoyang, Wuhan, Suzhou, Nanchong, Tianjin
2023-09-11
Rows per page Showing 201–300 of 421
Previous 1 2 3 4 5 Next
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Chinese investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 24 September 2026. https://priyalifescience.com/clinical-trials-china/city/suzhou?page=3

Query this register directly
GET /api/trials?country=cn&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in China and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 19,052 studies in total at the last sync on 22 Sep 2026, 11:10 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 421 of those studies with a site in Suzhou.

How many clinical trials are recruiting in Suzhou?

269 of the 421 studies on this page are recruiting new participants as of the 22 Sep 2026, 11:10 UTC sync. A further 53 have not yet opened recruitment, 87 are active but closed to new participants, and 12 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and India registers.